Urine culture grew Escherichia coli and Candida albicans; how should I treat this infection?

Management of Urine Culture Growing E. coli and Candida albicans

For a urine culture positive for both E. coli and Candida albicans, you must first determine whether the patient has urinary symptoms—if symptomatic, treat the E. coli with trimethoprim-sulfamethoxazole (or an alternative based on susceptibilities) and add fluconazole 200 mg daily for 14 days; if asymptomatic, treat only the E. coli unless the patient is neutropenic, a very low-birth-weight neonate, or scheduled for urologic procedures. 1, 2, 3, 4

Initial Clinical Assessment

Determine symptom status immediately:

• Symptomatic infection is defined by dysuria, urinary frequency, urgency, suprapubic pain, flank pain, or fever >38.3°C 1, 2
• Asymptomatic candiduria represents colonization in >95% of cases and does not require antifungal therapy in most patients 1, 2

Management Algorithm

Step 1: Remove Predisposing Factors (All Patients)

• Remove any indwelling urinary catheter immediately—this single intervention clears candiduria in approximately 50% of cases without antifungal therapy 1, 2, 5
• Discontinue unnecessary broad-spectrum antibiotics that may be promoting Candida overgrowth 2, 6

Step 2: Treat E. coli Bacteriuria

• For E. coli urinary tract infection, trimethoprim-sulfamethoxazole is FDA-approved and appropriate for susceptible strains 3
• Review local susceptibility patterns for E. coli fluoroquinolone resistance before selecting empiric therapy 1
• Tailor antibiotic therapy once susceptibility results are available 1

Step 3: Decide on Candida Treatment Based on Clinical Context

Asymptomatic Patients (No Antifungal Therapy Needed)

• Do not treat asymptomatic candiduria in otherwise healthy individuals, diabetic patients without additional risk factors, or elderly patients—treatment does not reduce mortality or improve outcomes 1, 2
• Candiduria progresses to candidemia in <5% of cases and serves primarily as a marker of illness severity 1, 2

High-Risk Asymptomatic Patients (Antifungal Therapy Required)

Even without symptoms, treat candiduria in these populations:

• Neutropenic patients with persistent unexplained fever—risk of disseminated candidiasis 1, 2
• Very low-birth-weight neonates (<1500 g)—high propensity for invasive disease 1, 2
• Patients scheduled for urologic procedures or instrumentation within several days—give fluconazole 200–400 mg daily for several days before and after the procedure 1, 2
• Patients with urinary tract obstruction that cannot be promptly relieved 2

Symptomatic Patients (Antifungal Therapy Required)

For symptomatic Candida cystitis (lower UTI):

• Fluconazole 200 mg (3 mg/kg) orally once daily for 14 days is first-line therapy for fluconazole-susceptible C. albicans—this is based on the only randomized, double-blind, placebo-controlled trial demonstrating efficacy 1, 2, 4
• Fluconazole achieves high urinary concentrations of active drug, ensuring effective pathogen eradication 1, 2, 5

For symptomatic Candida pyelonephritis (upper UTI):

• Fluconazole 200–400 mg (3–6 mg/kg) orally once daily for 14 days—use the higher 400 mg dose when upper-tract involvement is confirmed by flank pain, fever, or imaging 1, 2

Step 4: Species-Specific Considerations

• Candida albicans is usually fluconazole-susceptible, making fluconazole the appropriate choice 1
• If culture later identifies fluconazole-resistant species (C. glabrata or C. krusei), switch to amphotericin B deoxycholate 0.3–0.6 mg/kg IV daily for 1–7 days 1, 2

Critical Pitfalls to Avoid

• Do not use echinocandins (caspofungin, micafungin, anidulafungin) for urinary Candida infections—they achieve inadequate urine concentrations despite the single case report of success 2, 7
• Do not use voriconazole or posaconazole for urinary tract infections—insufficient urinary levels 2, 5
• Do not rely on colony counts or pyuria to distinguish colonization from infection, especially in catheterized patients 1, 2
• Do not continue indwelling catheters during treatment—this is the most common cause of treatment failure 2

Follow-Up and Reassessment

• If symptoms persist beyond 48–72 hours, obtain renal or bladder imaging (ultrasound or CT) to exclude obstruction, fungal balls, or abscesses 2
• For recurrent candiduria after appropriate treatment, evaluate for underlying urologic abnormalities such as strictures, stones, or prostatic disease 2
• Fungal balls or casts in the renal pelvis or bladder require surgical or endoscopic removal in addition to systemic antifungal therapy 1, 2, 8

Summary Treatment Table

Clinical Scenario	E. coli Treatment	Candida Treatment
Asymptomatic, low-risk	TMP-SMX per susceptibilities [3]	None—observation only [1,2]
Asymptomatic, high-risk (neutropenic, neonate, pre-procedure)	TMP-SMX per susceptibilities [3]	Fluconazole 200–400 mg daily [1,2]
Symptomatic cystitis	TMP-SMX per susceptibilities [3]	Fluconazole 200 mg daily × 14 days [1,2,4]
Symptomatic pyelonephritis	TMP-SMX per susceptibilities [3]	Fluconazole 200–400 mg daily × 14 days [1,2]